Aug. 27, 2008 — Electrocardiographically gated 64-multidetector row coronary computed tomographic angiography (CCTA) was 99 percent as effective in ruling out obstructive coronary artery stenosis as the more expensive and invasive coronary angiography traditionally used by physicians, according to a multi-center study on the accuracy of cardiac imaging technology.

The study, funded by GE Healthcare and led by Matthew J. Budoff, M.D., a principal investigator at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, was conducted at 16 different sites with 230 volunteers with chest pain but no known coronary artery disease.

Researchers used electrocardiographically gated 64-multidetector row coronary computed tomographic angiography (CCTA) to examine the research volunteers. Each volunteer also underwent the more expensive and invasive coronary angiography for evaluating coronary artery stenosis.

The researchers found CCTA provided high diagnostic accuracy for detection of obstructive coronary stenosis at the thresholds of a 50 percent narrowing and at 70 percent stenosis. It also found CCTA was accurate 99 percent of the time in ruling out coronary artery stenosis.

The study, “Diagnostic Performance of 64-Multidetector Row Coronary Computed Tomographic Angiography for Evaluation of Coronary Artery Stenosis in Individuals Without Known Coronary Artery Disease,” appears in the Journal of the American College of Cardiology.

For more information: www.acc.org


Related Content

News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Time March 30, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
News | Radiology Imaging

March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as ...

Time March 23, 2026
arrow
News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Lung Imaging

March 11, 2026 — Noah Medical has announced the publication of the MATCH 2 study in the international, peer-reviewed ...

Time March 12, 2026
arrow
News | Computed Tomography (CT)

March 5, 2026 — At ECR 2026, Royal Philips introduced Rembra, its next-generation radiology CT system designed for the ...

Time March 09, 2026
arrow
Feature | Artificial Intelligence | Kyle Hardner

Once considered an adjunct brain cancer therapy and a last-resort treatment, noninvasive radiosurgery has evolved ...

Time March 09, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
Subscribe Now